Cutaneous dermatomyositis disease course followed over time using the Cutaneous Dermatomyositis Disease Area and Severity Index.

ABSTRACT:

Background

Limited studies describe the longitudinal course of cutaneous dermatomyositis (DM).

Objective

To characterize disease course in treated cutaneous DM by using the Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI), a validated outcome instrument.

Methods

A retrospective cohort included patients with DM who had their CDASI activity subscore recorded for at least 2 years. Disease progression was classified as improved, worsened, or stable, and disease course was classified as monophasic, polyphasic, or chronic. Subjects were divided into groups with disease of mild (n = 16) and moderate-to-severe (n = 24) baseline severity.

Results

A total of 40 patients with DM met inclusion criteria. The majority demonstrated improvement in disease acti

SUBMITTER: Chansky PB 

PROVIDER: S-EPMC9094620 | biostudies-literature | 2018 Sep

REPOSITORIES: biostudies-literature